Sir, To prevent microbial contamination and subsequent infection of the newborn during birth, it would be desirable to have a safe and efficacious antimicrobial agent that could be applied to the vaginal mucosa to prevent transmission of neonatal pathogens during labour. We studied the in-vitro activities of three possibly useful agents: chlorhexidine, hexetidine and bacitracin against clinical isolates of Chlamydia trachomatis (5 strains), Ureaplasma urealyticum (4), Mycoplasma hominis (4), Streptococcus agalactiae (50), Escherichia coli (50) and Listeria monocytogenes (10). Reference strains were C. trachomatis ATCC VR348B, U. urealyticum ATCC 27618 and ATCC 27813, M. hominis ATCC 14027 and ATCC 23114, S. agalactiae ATCC 13813 and NTCC 8181, E. coli ATCC 25922 and Staphylococcus aureus ATCC 29213.
Susceptibility testing of S. agalactiae, E. coli, L. monocytogenes and S. aureus was performed by broth dilution in microtitre plates according to the guidelines of the NCCLS. Bacteria were grown on blood agar overnight at 37°C. Serial dilutions of the three test drugs were prepared in Iso-sensitest broth (Oxoid CM 473, Basingstoke, UK) in microtitre plates containing final concentrations of 0.25-1024 mg/L of chlorhexidine, 4-256 mg/L of hexetidine and 1.0-8192 mg/L of bacitracin per well; 100 //L of each dilution were mixed with an equal volume containing 10*cfu of each bacterial strain in broth. Plates were incubated for 18 h at 37°C and the MIC was read as the lowest concentration of each drug completely inhibiting growth.
Strains of M. hominis were grown in 65.5 mL PPLO broth (Difco 0554, Detroit, USA) supplemented with 10 mL yeast extract, 10 mL horse serum, 10 mL L-arginine hydrochloride, 1.5 mL thallium acetate, 0.002% w/v phenol red and 1000 IU/mL penicillin (final pH 7.0). Strains of U. urealyticum were cultured in 90 mL 3% w/v Trypticase Soy broth (Oxoid CM 129, Basingstoke, UK) supplemented with 3.6 mL yeast extract, 24 mL inactivated horse serum, 3 mL 40% w/v urea, 0.002% w/v phenol red, 40 mg/L cefuroxime and 4 mg/L amphotericin B (final pH 6.0). A suspension of 20,000 colour changing units/mL was mixed with 1 mL of each dilution of each drug, incubated for 30 min at 37°C and diluted 100-fold in broth medium. One mL was then pipetted into four culture tubes which were incubated for 72 h at 37°C. The MIC was read as the lowest concentration of each drug to inhibit growth in all four tubes.
Strains of C. trachomatis were grown on McCoy cells in flat bottom tubes as described by Heessen & Muytjens (1984) . Growth medium consisted of Eagle's MEM with HEPES 20mM, 3% inactivated fetal bovine serum, 6 g/L glucose, 50 mg/L gentamicin, 100 mg/L vancomycin, 2.5 mg/L fungizone and 1 mg/L cycloheximide. After inoculation, centrifugation (60 min at 3000 rpm) and incubation (72 h at 37°C), cultures were homogenized, fixed with methanol and stained with monoclonal antibodies for demonstration of inclusion bodies by immunofluorescence. A suspension of 20,000 inclusion forming units/mL was mixed with 1 mL of each dilution of test drug, left for 30 min, diluted 100-fold in chlamydia growth medium and 1 mL was inoculated on to each of four culture tubes and screened for inclusions after 72 h at 37°C. The MIC was defined as the lowest concentration of each drug completely inhibiting formation of inclusions.
The results of the in-vitro tests are given in the Table. Hexetidine did not inhibit C. trachomatis and E. coli, but was highly active against the other organisms; bacitracin only inhibited Gram-positive organisms; all strains were susceptible to 512 mg/L chlorhexidine or less. Although hexetidine was found to reduce the vaginal microflora by preoperative application (Wewalka el al., 1991 , Weidinger et al., 1991 , we think that it would be unsuitable for perinatal antisepsis, it not being active against E. coli and C. trachomatis which are significant neonatal pathogens. The same conclusion was made for bacitracin. For chlorhexidine we calculated that 10 mL of 1% chlorhexidine solution would result in local concentrations of 0.4 mg/cm ! assuming the surface area of the normal vagina during labour being about 250 cm ! . This concentration is far above the highest MIC for the organisms tested, being the volumetric MIC of 512 mg/L equivalent to 0.064 mg/cm 2 . This is in agreement with the experience that chlorhexidine can indeed prevent neonatal transmission of S. agalactiae (Kollee et al., 1989; Burman et al., 1992) . Chlorhexidine has been used in obstetrics and gynaecology for several purposes and is not absorbed to any large extent (Vorherr et al., 1984) , making it a safe substance. It may be of interest to study the efficacy of routine vaginal application of chlorhexidine in the prevention of several neonatal infections. 
